Navigation Links
Sigma-Aldrich (Nasdaq: SIAL) Reports Fourth Quarter Diluted EPS of $0.68. Ends 2008 With Record Sales and Earnings and Raises Quarterly Cash Dividend by 11.5%. Provides Outlook for 2009.
Date:2/11/2009

reasury (1,935.3) (1,534.1) Retained earnings 2,954.4 2,679.3 Accumulated other comprehensive income 25.3 159.9 Total stockholders' equity 1,379.2 1,616.6 Total liabilities and stockholders' equity $2,556.5 $2,629.1 SIGMA-ALDRICH CORPORATION Consolidated Statements of Cash Flows (Unaudited) (in millions) Twelve Months Ended December 31, 2008 2007 Cash flows from operating activities: Net income $341.5 $311.1 Adjustments to reconcile net income to net cash provided by operating activities: Depreciation and amortization 98.6 97.8 Deferred income taxes 18.1 (21.7) Stock-based compensation expense 12.2 19.0 Loss on equity investments, net 5.3 0.2 Other 1.7 (2.6) Changes in assets and liabilities: Increase in accounts receivable (4.0) (7.3) Increase in inventories (37.5) (25.2) Increase/(decrease) in accrued income taxes (0.1) 25.0 Increase/(decrease) in accrued pension obligation (20.6) 2.6 Other (11.2) 18.1 Net cash provided by operating activities 404.0 417.0 Cash flows from investing activities: Property, pl
'/>"/>
SOURCE Sigma-Aldrich
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related biology technology :

1. Sigma-Aldrich (Nasdaq: SIAL) Declares Quarterly Dividend
2. Sigma-Aldrich and Lab Manager Magazine Present Webinar On Laboratory Environmental, Health and Safety Compliance Strategies
3. Sigma-Aldrich Expansion in Republic of China to Support SAFC Growth
4. Sigma-Aldrich and Ingenuity Systems Announce Partnership to Create E-Commerce Search Solution Based on Biological Knowledge
5. Sigma-Aldrich to Present at the UBS 2007 Global Life Sciences Conference on September 25, 2007
6. Sigma-Aldrich Names Patrick Sullivan New VP of Research and Development for Research Biotech
7. Sigma-Aldrich and the Universite de Montreal Establish Collaboration for RNA Interference Studies
8. Sigma-Aldrich Corporations 3rd Quarter 2007 Earnings Conference Call
9. Sigma-Aldrich Introduces N-TER Nanoparticle siRNA Transfection System for Delivery of siRNA Into Difficult-to-Transfect Cell Types
10. Sigma-Aldrich (Nasdaq: SIAL) Q3 2007 Sales Increase 14.0%, Yielding Diluted EPS of $.54.
11. Sigma-Aldrich and Oxford BioMedica Win Key Ruling in Open Biosystems Patent Infringement Dispute
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... ... July 29, 2015 , ... ... introduces CHRONO NIGHT Express Contouring Bi-Gel, a nighttime-specific product that targets fat cells ... sugars that are able to enter fat cells, inhibiting the formation of new ...
(Date:7/29/2015)... ... ... Nearly everyone has heard of the potential of stem cells to treat a ... these cells is teeth—baby teeth that come loose during childhood, wisdom teeth extracted from ... for braces. These potent stem cells exist in the dental pulp of healthy ...
(Date:7/28/2015)... INCLINE VILLAGE, Nev. , July 28, 2015 /PRNewswire/ ... PDLI ) today announced that the Company will release ... ended June 30, 2015, on Wednesday, August 5, 2015, ... call and webcast that day at 4:30 p.m. Eastern ... relating to the call will be available via the ...
(Date:7/28/2015)... DUBLIN , July 21, 2015 ... ) has announced the addition of the ... report to their offering. Globally, ... applications including immuno-phenotyping, cell proliferation, cancer, and stem ... in clinical applications primarily because of demand from ...
Breaking Biology Technology:Phytocéane introduces CHRONO NIGHT Express Contouring Bi-Gel 2Phytocéane introduces CHRONO NIGHT Express Contouring Bi-Gel 3Advanced Oral and Maxillofacial Surgery (AOMS) in Elmhurst, IL Partners with Provia Labs to make Store-A-Tooth™ Dental Stem Cell Banking Available to their Patients 2PDL BioPharma to Announce Second Quarter 2015 Financial Results on August 5, 2015 2Analysis of the Global Flow Cytometry Market 2012-2018 with a 2014 Base Year and a 2015-2018 Forecast Period 2
... be Delivered by November 2007, BARCELONA, Spain, ... II trial includes 332 patients,with Overactive Bladder (OAB) ... 11,countries (US, Germany, Spain, The Netherlands, Czech Republic, ... The company,expects to report the results of this ...
... Calif., Oct. 9 VNUS(R) Medical,Technologies, Inc. (Nasdaq: ... minimally invasive treatment of peripheral vascular disease,announced today that ... third,quarter ended September 30, 2007, before market opens on ... quarterly teleconference at 5:30 a.m. PT,/ 8:30 a.m. ET ...
... Bavarian Nordic,the Danish-based international biopharmaceutical company, has ... Services (HHS) to,invoice an advance payment of $50 ... manufacture and deliver 20 million doses of the,company,s, ... payment because Bavarian Nordic fulfilled a,number of significant ...
Cached Biology Technology:SALVAT has Completed Patient Enrollment in a Dose Finding Phase II Trial of SVT-40776 for the Treatment of Overactive Bladder 2VNUS Medical Technologies to Report Third-Quarter 2007 Results and Webcast Teleconference on October 29 2Bavarian Nordic Receives $50 Million Advance Payment from HHS for Fulfilling Contract Milestones 2Bavarian Nordic Receives $50 Million Advance Payment from HHS for Fulfilling Contract Milestones 3
(Date:7/27/2015)... LOS ANGELES , July 27, 2015 /PRNewswire/ ... providing evidence- and experience-based clinical improvement solutions, today ... coordination solution is now available on Android smartphones ... at inpatient and post-care organizations can use ZynxCarebook ... the same patient,s condition, streamline care transitions to ...
(Date:7/21/2015)... Connecticut , July 21, 2015  NXT-ID, ... "Company"), a biometric authentication company focused on the ... Wocket® smart wallet, announces that it has filed ... System and Method. This invention ... not only authorizes an account, but also the ...
(Date:7/13/2015)... Jul. 13, 2015 NXT-ID, Inc. (NASDAQ: ... authentication company focused on the growing mobile commerce ... patent 62/188684 for BEHAVIORAL-DIRECTED AUTHENTIATION METHOD ... convenient and secure method to make payments.  With ... methods, introduced with its groundbreaking voice-direct payment patent ...
Breaking Biology News(10 mins):Zynx Health Adds Android Device Support to ZynxCarebook Solution 2Zynx Health Adds Android Device Support to ZynxCarebook Solution 3NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 2NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 3NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 4NXT-ID Patents Behavior-Directed Payments 2NXT-ID Patents Behavior-Directed Payments 3NXT-ID Patents Behavior-Directed Payments 4
... 130 osteoporosis patient society representatives gathered in Valencia, Spain ... Conference of Osteoporosis Patient Societies. Osteoporosis is ... fractures in as many as one in two women ... 50 worldwide. International Osteoporosis Foundation (IOF) CEO Patrice ...
... the Chair of the Department of Zoology and Neurobiology at ... a week after birth, they eliminated a particular protein in ... cells. "It,s the first time that we have gained an ... "We can now start conducting research to develop new therapeutic ...
... a subtropical, deciduous fruit tree grown in most Mediterranean-type ... oldest cultivated fruit species on earth, global expansion of ... base pertaining to production practices and the limited number ... were established in the Mediterranean-type climate of Western Cape ...
Cached Biology News:Important role for the cerebellum 2Optimizing yield and fruit size of figs 2
Human peripheral blood neutrophils, For immunohistochemistry (IHC) Cell Chip with Human Peripheral Blood Granulocytes...
Human endothelial progenitor cells, For immunohistochemistry (IHC) Cell Chip with Human Peripheral Blood Dendritic Cells and EPCs...
Umbilical cord blood neutrophils, For immunohistochemistry (IHC)...
...
Biology Products: